Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor ‐forming potential in an early‐stage prostate cancer epithelial subline (M2205)
ConclusionThese results support using OGM as a tool to analyze solid tumors in clinical/research settings. Moreover, this OGM analysis expanded the characterization of cytogenetic changes present in the M2205 subline, including alterations associated with tumors from Black males diagnosed with prostate cancer.
Source: Molecular Genetics & Genomic Medicine - Category: Genetics & Stem Cells Authors: Prabakaran Paulraj,
Elizabeth Barrie,
Colleen Jackson ‐Cook Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Genetics | Prostate Cancer | Study | Translocation